Most lately, it's been identified that conolidine and the above derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in very similar regions as classical opioid receptors, it binds to your wide array of endogenous opioids. Not like most opioid receptors, this receptor acts to be a scavenger https://mickh736svw4.activoblog.com/profile